Toni Choueiri, MD
@DrChoueiri
Chief GU Cancers @DanaFarber; Prof Medicine @HarvardMed; ⚽ lover; 🚲@PanMass rider.
Help us reach $700 raised to support cancer care at @DanaFarber! charity.pledgeit.org/pickleball/tea… 🎟 Every $25 donated = 1 entry to win 2 spectator tickets to the Gronk Pickleball Fundraiser! Want to cheer us on? Tickets also available on our website.
From the stage to the crowd, from data to patients, KCRS25 is all about accelerating cures together. Brilliant minds, real impact. Every voice, every effort counts. #KCRS25 #KidneyCancer @OncoAlert @kidneycan @DrChoueiri @KimrynRathmell @advocatekidneys @DrRanaMcKay @arihakimi
And that is wrap for #KCRS2025 @HHammersMD @advocatekidneys @kidneycan
What we did in Boston this week at #KCRS2025 will change lives worldwide. Scientists, doctors,patients, industry, and advocates—all in one room—accelerating cures + driving hope. Thank you @KidneyCAN for this powerful, patient-focused gathering. #KidneyCancer #ResearchToCures
A Patient’s Call to Action to Our Care Teams in Uncertain Times @kidneycan @DanaFarber_GU @DrChoueiri linkedin.com/posts/chuckstr…
A force of nature, a catalyst for change and an incomparable energy ! Congrats @DrRanaMcKay @UCSDCancer ! @kidneycan #KCRS2025
We’re proud to present the KidneyCAN Catalyst Award to Dr. Rana McKay of UC San Diego. Dr. McKay is a leader whose work has helped move the field of kidney cancer forward through groundbreaking research, clinical collaboration, and a deep commitment to patients and advocacy. Her…
Grants and awards @kidneycan #KCRS2025. Congratulations @DrRanaMcKay @UCSDCancer and @srviswanathan @DanaFarber
Year 7 of @kidneycan #KCRS2025 and it all started with my co-chair @HHammersMD !
A032201/Adjuvant RCC trial now enrolling! @ALLIANCE_org #KCRS25 open @DanaFarber_GU and over 200 sites nationwide! Glad to see it discussed on the main stage cancer.gov/research/parti…
Microbiome expert @CarolinaAlvesC5 elegantly presentsthe data on MAdCAM-1 in association with outcomes to IO-based therapies Circulating MadCAM-1 is a promising baseline and dynamic biomarker I love our 💩team! @MarcMachaalani #KCRS25 @OncoAlert
Join us #KCRS2025 —unmissable how to design and excite from other trials and bring them into kidney cancer —@kidneycan @VivekSubbiah @montypal
Just came online in @TheLancet 👉Our two papers on improved OS with Enzalutamide + Talazoparib in mCRPC #ProstateCancer in all-comer & HRRm patients (Median OS and HRs👇). Weblinks to the papers👉 bit.ly/4lXkLtB and bit.ly/4nNIyOh @PCFnews @urotoday @OncoAlert
Just in👉Two @TheLancetOncol papers on patient-reported QOL results in ph3 TALAPRO-2 trial👉in all-comer & HRR deficient mCRPC #ProstateCancer pts👉Improved OS without compromising QOL👇Links: bit.ly/3DWHlSR & bit.ly/3E3SSQi @urotoday @OncoAlert @PCFnews 👇
#KCRS25 Oral Abstract: @MarcMachaalani @DanaFarber highlights KIM-1 as a potential blood biomarker to predict RCC treatment response and prognosis. Read all the abstracts: bit.ly/AbstractsKCRS25 Register: bit.ly/RegisterKCRS25 #AcceleratingCures
Let us do this ! #KCRS2025 @kidneycan @advocatekidneys @DrRanaMcKay @HHammersMD @montypal @arihakimi @tompowles1
Just three days until KCRS 2025! We’re getting ready to welcome researchers, clinicians, advocates, and patients from around the world to explore the future of #KidneyCancer research. #KCRS25 #AcceleratingCures
The role of ultra-processed food (UPF) in obesity | @NatureRevEndo —time to sound the alarm 🚨 on UPF! Nice review that focus on the biological link between UPF and Obesity nature.com/articles/s4157…
Fascinating paper in @Cancer_Cell by @CharlesSwanton => direct functional evidence for cancer cell-intrinsic subclonal immune evasion in 3 different settings in lung cancer: different subclones = different responses to immune pressure
Today, serum KIM-1 is the biomarker to explore in all stages of RCC, via @eufocus pubmed.ncbi.nlm.nih.gov/40619332/
Huge Congratulations 🎉 to Dr. @lalaniMD (former @DanaFarber_GU post-doc) who keeps pushing the boundaries and excelling, now @JuravinskiRI in Canada 🇨🇦!
Thank you @JuravinskiRI for this award to launch ELEVATe-PM! We aim to integrate innovative MRD blood tests in the curative setting - starting with RCC, bladder cancer, & AML - while harnessing AI/data analytics to enhance efficiencies @HamHealthSci @McMasterU @StJoesHamilton
Congrats @RashadNawfal @KarlSemaan and all outstanding mentors ! @DanaFarber_GU @DanaFarber
1/ Happy to share our latest piece in @Nature_NPJ precision oncology: "Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancer". Work co-led with @KarlSemaan with great mentorship from @Jberchuck @SylvanBacaLab #MattFreedman @DrChoueiri…